Intramedullary melanotic schwannoma of the cervical spine: A case report and literature review

Hu,Ling; Wang,Chao

doi:10.3892/mco.2018.1584

Intramedullary melanotic schwannoma of the cervical spine: A case report and literature review

Authors:
- Ling Hu
- Chao Wang
View Affiliations

Affiliations: Department of Ultrasound, Hangzhou Women's Hospital, Hangzhou, Zhejiang 310016, P.R. China, Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China
Published online on: February 27, 2018 https://doi.org/10.3892/mco.2018.1584
Pages: 567-570

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Intramedullary melanotic schwannomas (IMS) are rare lesions, with only 8 cases reported in the literature to date. We herein describe the case of a 40‑year‑old male patient with an IMS of the cervical cord, which, to the best of our knowledge, is the ninth reported case of IMS, and review the relevant literature. The patient presented with numbness of the left arm that gradually worsened over a period of 4 months. Magnetic resonance imaging (MRI) of the cervical spine with gadolinium enhancement revealed an intramedullary lesion at the level of C1‑C2. The mass was T1 hyperintense, T2 hypointense and homogeneously enhanced. During surgery, an intramedullary dark gray lesion was identified and was partially removed. The left arm numbness partially subsided 2 weeks after surgery. Although rare, IMS is associated with characteristic MRI findings (T1 hyperintensity, T2 hypointensity and homogeneous enhancement) and MRI is the preferred method for evaluating lesions of the spinal cord. Correct diagnosis is crucial for management planning; therefore, immunohistochemical examination is required. In addition, IMS cases must be closely followed up, particularly when the mass cannot be completely resected.

View Figures

View References

1	Ishihara S, Horiguchi A, Miyakawa S, Endo I, Miyazaki M and Takada T: Biliary tract cancer registry in Japan from 2008 to 2013. J Hepatobiliary Pancreat Sci. 23:149–157. 2016. View Article : Google Scholar : PubMed/NCBI
2	Wakai T, Shirai Y, Sakata J, Maruyama T, Ohashi T, Korira PV, Ajioka Y and Hatakeyama K: Clinicopathological features of benign biliary strictures masquerading as biliary malignancy. Am Surg. 78:1388–1391. 2012.PubMed/NCBI
3	Burnett AS, Calvert TJ and Chokshi RJ: Sensitivity of endoscopic retrograde cholangiopancreatography standard cytology: 10-y review of the literature. J Surg Res. 184:304–311. 2013. View Article : Google Scholar : PubMed/NCBI
4	Navaneethan U, Njei B, Lourdusamy V, Konjeti R, Vargo JJ and Parsi MA: Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: A systematic review and meta-analysis. Gastrointest Endosc. 81:168–176. 2015. View Article : Google Scholar : PubMed/NCBI
5	Yonezawa S, Higashi M, Yamada N, Yokoyama S and Goto M: Significance of mucin expression in pancreatobiliary neoplasms. J Hepatobiliary Pancreat Sci. 17:108–124. 2010. View Article : Google Scholar : PubMed/NCBI
6	Moschovis D, Bamias G and Delladetsima I: Mucins in neoplasms of pancreas, ampulla of Vater and biliary system. World J Gastrointest Oncol. 8:725–734. 2016. View Article : Google Scholar : PubMed/NCBI
7	Inagaki Y, Xu H, Nakata M, Seyama Y, Hasegawa K, Sugawara Y, Tang W and Kokudo N: Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers. Biosci Trends. 3:220–232. 2009.PubMed/NCBI
8	Tang W, Inagaki Y, Kokudo N, Guo Q, Seyama Y, Nakata M, Imamura H, Sano K, Sugawara Y and Makuuchi M: KL-6 mucin expression in carcinoma of the ampulla of Vater: Association with cancer progression. World J Gastroenterol. 11:5450–5454. 2005. View Article : Google Scholar : PubMed/NCBI
9	Xu HL, Inagaki Y, Seyama Y, Sugawara Y, Kokudo N, Nakata M, Wang FS and Tang W: Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion. Life Sci. 85:395–400. 2009. View Article : Google Scholar : PubMed/NCBI
10	Tang W, Guo Q, Qu X, Inagaki Y, Seyama Y, Midorikawa Y, Gai R, Kokudo N, Sugawara Y, Nakata M and Makuuchi M: KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma. Oncol Rep. 17:737–741. 2007.PubMed/NCBI
11	Xu H, Inagaki Y, Tang W, Guo Q, Wang F, Seyama Y, Midorikawa Y, Gai R, Kokudo N, Sugawara Y, et al: Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma. Hepatogastroenterology. 55:2000–2004. 2008.PubMed/NCBI
12	Matsumoto K, Takeda Y, Harada K, Onoyama T, Kawata S, Horie Y, Sakamoto T, Ueki M, Miura N and Murawaki Y: Clinical impact of the KL-6 concentration of pancreatic juice for diagnosing pancreatic masses. Biomed Res Int. 2015:5283042015. View Article : Google Scholar : PubMed/NCBI
13	Cotton PB, Garrow DA, Gallagher J and Romagnuolo J: Risk factors for complications after ERCP: A multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 70:80–88. 2009. View Article : Google Scholar : PubMed/NCBI
14	Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, Pilotto A and Forlano R: Incidence rates of post-ERCP complications: A systematic survey of prospective studies. Am J Gastroenterol. 102:1781–1788. 2007. View Article : Google Scholar : PubMed/NCBI
15	Sadeghi A, Mohamadnejad M, Islami F, Keshtkar A, Biglari M, Malekzadeh R and Eloubeidi MA: Diagnostic yield of EUS-guided FNA for malignant biliary stricture: A systematic review and meta-analysis. Gastrointest Endosc. 83:290–8.e1. 2016. View Article : Google Scholar : PubMed/NCBI
16	Weilert F, Bhat YM, Binmoeller KF, Kane S, Jaffee IM, Shaw RE, Cameron R, Hashimoto Y and Shah JN: EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: Results of a prospective, single-blind, comparative study. Gastrointest Endosc. 80:97–104. 2014. View Article : Google Scholar : PubMed/NCBI
17	De Moura DT, Moura EG, Bernardo WM, De Moura ET, Baracat FI, Kondo A, Matuguma SE and Artifon EL: Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: Systematic review and meta-analysis. Endosc Ultrasound. Nov 8–2016.(Epub ahead of print).
18	Heimbach JK, Sanchez W, Rosen CB and Gores GJ: Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB(Oxford). 13:356–360. 2011.PubMed/NCBI
19	Bonella F, Long X, Ohshimo S, Horimasu Y, Griese M, Guzman J, Kohno N and Costabel U: MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis. Orphanet J Rare Dis. 11:482016. View Article : Google Scholar : PubMed/NCBI